Results 221 to 230 of about 9,553,129 (275)

Determining the half-life and turnover rate of EPA, n-3 docosapentaenoic acid, and DHA in humans using the natural abundance of carbon-13: a secondary analysis of a randomized clinical trial. [PDF]

Am J Clin Nutr
Symington A, Wu D, Chen CT, Del Vecchio M, Zahradka P, Taylor C, Aukema HM, Kong D, Metherel AH, Bazinet RP.   +9 more
europepmc   +1 more source

AI-directed gene fusing prolongs the evolutionary half-life of synthetic gene circuits. [PDF]

Sci Adv
Menuhin-Gruman I, Arbel-Groissman M, Naki D, Bergman S, Tuller T.   +4 more
europepmc   +1 more source

A First-in-Human, Single- and Multiple-Dose Study of APG777, a Half-Life-Extended Anti-IL-13 Monoclonal Antibody, in Healthy Volunteers. [PDF]

Clin Transl Sci
Lim XQ, Winter E, Nograles K, Xu J, Zhang ZQ, Thankamony S, Dillinger L, Dambkowski CL.   +7 more
europepmc   +1 more source

Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safety. [PDF]

MAbs
Siegel M, Zhu E, Rios D, Kang BH, McNally J, Kennedy M, Hew K, Patel P, Ballew O, Giles DH, Lewis EMA, LaFountaine J, Oh J, Friedman JR, Rose MJ, Shaheen H, Spencer AG.   +16 more
europepmc   +1 more source

²²⁵Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method. [PDF]

EJNMMI Res
Almaslamani M, Kim K, Kim KI, Lim I, Kim HA, Woo SK.   +5 more
europepmc   +1 more source

Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy. [PDF]

J Immunother Cancer
Bainbridge TW, Wang L, Moskalenko M, Herrera R, Paluch MT, Sun D, Tasneem K, Saini H, Sadek M, Kwong M, Kim YM, Bhatt JM, Tam C, Chan PPF, Ovacik AM, Masureel M, Zhao Y, Sockolosky JT, Qu Y, West NR, Bulutoglu B.   +20 more
europepmc   +1 more source

Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.

Blood
Byrne C, Ward S, O'Sullivan J, Chion A, Lopes P, Baci B, Dowd C, Jordan D, Baker R, Preston RJS, Monopoli M, Turecek PL, Kotsias M, Cheeseman J, Moran AB, Gardner RA, Spencer DIR, Atiq F, O'Donnell JS.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Half-life of 176Lu

Applied Radiation and Isotopes, 2006
The half-life of 176Lu, measured using gamma-ray spectrometry, has been found to be (3.56+/-0.07)x10(10)yr. Comparison has been made between present results and literature data.
Junhua Luo, Xiangzhong Kong
exaly   +3 more sources

The half-life of 18F

Applied Radiation and Isotopes, 2010
The half-life of the positron-emitter (18)F has been measured by following the decay rate with three systems: ionization chambers, Ge detectors and coincidence with fast scintillators. The decay rate was measured for periods of time up to 9 half-lives.
Eduardo Garcia-Torano
exaly   +3 more sources